Tbio AHNAK2 Protein AHNAK2

Protein Summary

Description

This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]

Uniprot Accession IDs

• Q8IVF2
• Q5BKX7
• Q7Z343
• Q7Z358
• Q7Z394
• Q7Z3G0
• Q86WQ6
• Q8IYY1
• Q8N3G4
• Q96EX9

Gene Name

• AHNAK2

Ensembl ID

• ENST00000333244
• ENSP00000353114
• ENSG00000185567
• ENST00000557457
• ENSP00000450998

Symbol

• C14orf78
• KIAA2019
• C14orf78

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
drug perturbation	1
small molecule perturbation	0.75
kinase perturbation	0.71
transcription factor perturbation	0.68
interacting protein	0.58

Protein Classes

No PANTHER Classes or DTO Classes found

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 25.66   (req: < 5)

Gene RIFs: 12   (req: <= 3)

Antibodies: 115   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 25.66   (req: >= 5)

Gene RIFs: 12   (req: > 3)

Antibodies: 115   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Term: 1

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0